Gila Therapeutics, Inc. is a biotechnology startup founded in April 2014 and located in Minneapolis, Minnesota. The company operates in the US healthcare and life sciences sector.
Subscribe to see Gila Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gila Therapeutics, Inc. is a biotherapeutics company headquartered in Edina, United States. It has raised at least $5.7M across the 7 funding rounds on record, 6 of them with a disclosed amount. Its most recent funding round, Debt - II, raised $400,000 in November 2023. Xcout tracks 6 named people at Gila Therapeutics, Inc., including Richard G. Horan (ACTING CEO & DIRECTOR).
As of 16 November 2026. Source: Xcout Intel.
At least $5.7M raised across the 7 rounds on record (6 with a disclosed amount). The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt - II | $400,000 | 1 named | |
| SEC Form D filing | $355,522 | — | |
| SEC Form D filing | $1.3M | — | |
| SEC Form D filing | $314,434 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Gila Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Good Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington. The firm focuses on drug discovery and the development of novel therapeutic pipelines and biopharmaceuticals.
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Glionova AB is a Sweden-based, development-stage biopharmaceutical company founded in 2014 that focuses on developing cancer prevention therapies and treatments for difficult-to-treat cancers. The company's pipeline includes small-molecule oncolytic drugs, featuring its lead candidate GLN-1001.
Cytotheryx is a biotechnology company based in Rochester, Minnesota, developing a platform technology to increase the supply of liver cells for pharmaceutical use.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Gila Therapeutics, Inc.? Suggest a correction · Work at Gila Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.